Updates for VA Clinicians in the Use of Bispecific Antibodies Across Later-Line Non-Hodgkin’s Lymphomas: Summarizing Current Efficacy and Safety Data Bi-specific antibodies for Non-hodgkin’s lymphoma treatment in Veterans Affairs patients: Current treatments, limitations and new promises